ARES three-lens brief
Evidence-based stock research on ARES. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Moved -2.78% yesterday. · 50-day MA below 200-day MA (death-cross regime); price below both.
- Moved -2.78% yesterday.
- 50-day MA below 200-day MA (death-cross regime); price below both.
- P/E of 62 — priced for high growth; little margin of safety.
- Ex-dividend date 2026-09-16.
ARES closed at $130.63 (-2.78%) as of 2026-09-11. Market cap: $43.34B. P/E (trailing) 61.6. Price is below the 50-day MA and below the 200-day MA. Concerns: moved -2.78% yesterday.; 50-day MA below 200-day MA (death-cross regime); price below both.. Last quarter: Revenue $1.16B, net income $308.88M, free cash flow $2.16B.
Why three lenses on ARES, not one.
A single reasoning model has blind spots it doesn’t know about. We examine ARESacross Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/ARES" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath ARES brief"></iframe>